Bortezomib: understanding the mechanism of action

Mol Cancer Ther. 2011 Nov;10(11):2029-30. doi: 10.1158/1535-7163.MCT-11-0745.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis*
  • Boronic Acids / pharmacology*
  • Humans
  • Multienzyme Complexes / antagonists & inhibitors*
  • Protease Inhibitors / pharmacology*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Pyrazines / pharmacology*
  • Tosylphenylalanyl Chloromethyl Ketone / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Multienzyme Complexes
  • Protease Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • Pyrazines
  • Tosylphenylalanyl Chloromethyl Ketone